{
    "links": "https://www.ycombinator.com/companies/macromoltek",
    "name": "Macromoltek",
    "headline": "Computational antibody design",
    "batch": "W18",
    "description": "Macromoltek: Revolutionizing antibody design.\r\n\nDescription:  Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.",
    "activity_status": "Active",
    "website": "https://www.macromoltek.com",
    "founded_date": 2010.0,
    "team_size": 14.0,
    "location": "Austin, TX",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:ai-powered-drug-discovery; industry:deep-learning; industry:therapeutics; location:austin",
    "founders": [
        {
            "name": "Monica Berrondo, Founder/CEO",
            "description": "Monica Berrondo, Ph.D., is an entrepreneur, scientist, and software engineer. Her expertise lies in antibody structure-prediction and analysis, protein functional analysis, protein mutational analysis, and computational approaches to complex scientific problems.",
            "linkedin": "https://www.linkedin.com/in/monicaberrondo"
        },
        {
            "name": "Susana Kaufmann, Founder/CTO",
            "description": null,
            "linkedin": "https://www.linkedin.com/in/susanakaufmannn"
        }
    ],
    "status": true,
    "generated_description": "**Macromoltek: Revolutionizing Antibody Design**\n\nFounded in 2010 and a proud member of Y Combinator's Winter 2018 batch, Macromoltek is an innovative company located in Austin, Texas. With a lean but capable team of 14 employees, they\u2019re at the forefront of computational drug discovery, specifically focused on the design of antibodies using cutting-edge technology.\n\n**Mission and Technology**\nMacromoltek's mission is clear: they aim to revolutionize antibody design by leveraging computational models to produce custom antibodies in just one week. Their proprietary platform allows them to tackle complex targets that traditional methods often fail to address. By combining proprietary algorithms with multidisciplinary expertise, Macromoltek is not just discovering new antibodies but also improving existing structures and humanizing therapeutic antibodies. They're also engaged in epitope mapping of antigens, which is crucial in the development of effective therapies.\n\n**Uniqueness and Value Proposition**\nWhat sets Macromoltek apart? It's their ability to deliver tailor-made solutions for specific antibody design problems, making them invaluable to both large biopharma companies and smaller biotech firms. Whether it\u2019s about improving existing antibodies or solving challenging design issues, they deliver credible results with speed and accuracy.\n\n**Current Activities and Reach**\nThey're actively transforming the landscape of antibody development and collaborating with notable partners, showcasing their contributions to the field of drug discovery. Their focus on AI-powered drug discovery, deep learning, and therapeutics positions them right at the intersection of technology and biology.\n\n**Let\u2019s Connect**\nTo learn more about their work, you can visit their [website](https://www.macromoltek.com) or check out their [blog](https://www.macromoltek.com/</blogs/1/>), where they share insights and updates on their technological advancements. You can also find them on [LinkedIn](https://www.macromoltek.com/<https:/www.linkedin.com/company/macromoltek-llc>) and [Twitter](https://www.macromoltek.com/<https:/twitter.com/Macromoltek>).\n\nIn a world where rapid advancements in science and technology are crucial, Macromoltek stands out as a beacon of innovative antibody design. If they continue on this path, they\u2019re sure to make a significant impact in the biopharmaceutical sector.",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/8c58432690cd82e354f1ca54ae63b15c6d773aef.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAEHIR6H6F%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191518Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDt736ZW5EfzagAz1eKRSs%2FW4TfHu28RBSFaRNkZ9h47gIhANt6WXtwkgL07bQKDKYDGFxYKx7WOO9JX0BqaYrXnKNbKu4DCNz%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMMDA2MjAxODExMDcyIgx8TqkMwTM2PLcRmr4qwgPGGtQBXv7gs7%2BXGteI1gQk%2FjkbIHwQ5hCKXJKVmVAPw3MeVLhZyp8Nf5%2FYigbwE%2BrFR7aZWKjrs7HxAE0JWit5dlINZLjZK%2BS%2FwMaCqoj%2BFDN0gw9iiAPu4Xn5c3b%2BuZe%2F5%2Flfk0EuxZAXVsZtShxXZy%2FERPQ0v%2FRZxSz5qUoaXpL1zj6VWdWVzoI7%2FPlB3bgJ2PpiF7DN%2BJeDsJPx%2FoKTo5ehP9pOeGbMNxoeegVJsCJ3zvzO3o4fcZYIf6c5iIJwM1Ot3Gg7Z3v9oLZjSRU%2FaRLL5j4n3II7DaroOCEVfPlWzTyZM7SNFZZAFSKM8vLKj1VdTr9s3How41zluf%2FOIp7sGNhG%2FjuYJoG%2FmkLFIlYP4wbGrLO69AWnenZyfi1UhAiV6N%2BlAqGnqvpOJh4vq8uNh2eRnXR%2BMVXdq9oVYkm7XFgprL5PDC4ULLyBWqA6kca4z7F4H56nkT%2FsDtT8ek2VOIRIv1Zgcz%2BeeVG7F7AHS4bdbR6eZ3ChY1iQhfPBErh4OiFQM7IqiUKw%2B1CTpvL68xcVN5gjiaDH0Jotw%2BUcW9dMSg9py8xH8qgyiWG5w3dDj9xaoA2G3NMYq6JOGKMwwIrjvQY6pAHDH54nhADhmb7YSEGxHkL3pqs%2B6aYOExStWbzLKzRb3lb2DAgGG8uU9COt8%2FqUEOtOcszTKp7yuCJwMVkfI7PDZ74h9uiRkRxjtH7%2BLlE1xrfd%2FrIq%2B%2BZr9hSFqZ9MUQ4yNHesyx2FYDbsIfCW9ntlrpmZUHCcrzpQDfufsAFcpe%2FudVT3tUqiF8WCN1Vd%2Bx%2FQ9d3i1HvBcJWV9AYAwM0W22VM%2BA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=8ca3f4fa8489ab5b7df59323b77be1562bd04b5a172a01d0dba1298bf6d1e8ac",
    "social_links": [
        "https://www.linkedin.com/company/macromoltek-inc/",
        "https://twitter.com/macromoltek",
        "https://www.crunchbase.com/organization/macromoltek-inc"
    ],
    "logo_path": "data/logos\\Macromoltek_logo.png"
}